Enzene Biosciences, a global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneX), has launched a new Drug Discovery Division—further expanding its breadth of services to the biotech industry and complementing its EnzeneX-equipped biologics manufacturing site, which will open later this summer in the U.S.   Enzene is introducing its new discovery arm to provide end-to-end integrated discovery services in response to the rapidly growing industry demands. The d...